Leaderboard

En | De
Sie sind hier: Gynäkologie » Mammae 18. November 2026
Suchen
medline.ch
Mammae
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Fortpflanzung
Genitale Erkrankungen
Infertilität
Mammae
Menopause
Schwangerschaft
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 11216  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 224314  
   
Cyclin Inhibitors in Advanced Breast Cancer: Evaluation of Toxicity in Older Patients.
Acta Med Port
Veiga F, Costa M, Marques R, Aranha R, Caramujo C, Malyarchuk V, Lopes Fernandes C, Basílio Leite J, Vilaça M, Salgado M, Pinho M, Nobre Carvalho A, Pinho Moreira S, Machado M.
PMID: 43045063 [PubMed - indexed for MEDLINE]


Clinicopathological and sonographic features and recurrence associations in pregnancy-associated breast cancer: A comparative study.
Clin Imaging
Zong Q, Mou Y, Deng J, Ge W, Yu F.
PMID: 43044375 [PubMed - as supplied by publisher]


Nanoparticle-mediated strategy to overcome delivery barriers and inhibit the BDNF/TrkB axis: A therapeutic approach for breast cancer brain metastasis.
Biochem Biophys Res Commun
Ali I, Muzzammil M, Afridi S, Shahi MH.
PMID: 43044328 [PubMed - as supplied by publisher]


Neoadjuvant talazoparib, irinotecan, and standard chemotherapy for early breast cancer in the I-SPY2 trial.
ESMO Open
Clark AS, Omene C, Yau C, Wallace AM, Stringer-Reasor E, Chien AJ, Isaacs C, Han HS, Albain KS, Boughey JC, Nanda R, Beckwith H, Mitri Z, Ellis ED, Elias AD, Lang JE, Shatsky R, Howard-McNatt M, Helsten T, Blair S, Woodard S, Parker C, Melisko M, Crane EP, Asare AL, Brown-Swigart L, Hirst GL, Matthews JB, Delson AL, Perlmutter J, Yee D, DeMichele AM, Rugo HS, Hylton NM, Symmans WF, van 't Veer LJ, Berry DA, Esserman LJ.
PMID: 43044269 [PubMed - as supplied by publisher]


Rethinking cardiac monitoring in patients receiving trastuzumab-based HER2-directed therapies for breast cancer: a meta-analysis and cost-effectiveness analysis.
ESMO Open
Saad Menezes MC, Barac A, Upshaw JN, Lin NU, Rabinowitz JB, DeMichele A, Hurvitz SA, Perez EA, Schwartz JH, Julian A, Mico V, Papatheodorou S, Tarantino P, Pandya A, Kunst N, Burstein HJ, Mayer EL, Tolaney SM, Schlam I.
PMID: 43044268 [PubMed - as supplied by publisher]


Effectiveness of remote symptom monitoring with clinical feedback in patients with breast cancer under active treatment: Systematic review and meta-analysis.
Eur J Cancer
de Almeida ABB, Squizzato FAT, de Oliveira LGAM, da Silva FPR, Oliveira HB, Oliveira GC, Sousa MO, Crusoe EQ.
PMID: 43044154 [PubMed - as supplied by publisher]


Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.
J Clin Oncol
Meduri B, Baldissera A, Iotti C, Scheijmans LJEE, Stam MR, Parisi S, Boersma LJ, Ammendolia I, Koiter E, Canino P, Busz DM, Kroese MS, Giacobazzi P, Ruggieri MP, Engelen A, Munafò T, Verhoeven K, Valli M, Vicini R, Costantini RC, D'Angelo E, Lohr F, D'Amico R, Frezza G, Poortmans P, for the IRMA Trialists, IRMA Trialists.
PMID: 43044095 [PubMed - as supplied by publisher]


An In vitro Experimental Study of the Cytotoxic and Antiproliferative Effects of Cabozantinib on Human Breast Cancer (Mcf-7) Cells.
Ann Afr Med
Manoharan A, Sharma S, Rawat A, Priyanka G, Anbumozhi MK, Johnson WMS.
PMID: 43043803 [PubMed - as supplied by publisher]


Internal mammary vessels as recipient vessels in supercharged ileocolon interposition for esophageal reconstruction: a single-center early technical experience.
Langenbecks Arch Surg
Papp A, Petrovics L, Vereczkei A, Papp C, Horvath OP, Pavlovics G.
PMID: 43043466 [PubMed - indexed for MEDLINE]


Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium.
Radiology
Sprague BL, Ponzini M, Sattayapiwat O, Eliassen MS, Nyante SJ, Tosteson ANA, Bowles EJA, Borowsky AD, Kerlikowske K, Lee CI, Perry H, Sowden M, Weaver DL, Miglioretti DL.
PMID: 43043180 [PubMed - indexed for MEDLINE]


Residual Pure Intralymphatic Breast Carcinoma After Neoadjuvant Therapy: Clinicopathologic Analysis and Comparative Outcomes Across Published Studies.
Arch Pathol Lab Med
Bahmad HF, Brachtel EF, Jorda M, Gomez-Fernández C, Tjendra Y.
PMID: 43042959 [PubMed - as supplied by publisher]


RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
J Natl Cancer Inst
Mokbel K, Mokbel K.
PMID: 43042713 [PubMed - as supplied by publisher]


Dual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges.
Front Med (Lausanne)
Su J, Wang B, Xiao H, Zhang Y.
PMID: 43042313 [PubMed]


Regulation and Tumor-Promoting Functions of PD-L1 in Breast Cancer: Mechanisms, Tumor Microenvironment, and Therapeutic Implications.
Breast Cancer (Dove Med Press)
Xiang Y, Wu TW, Gao Y, Chen WQ, Lu ZX.
PMID: 43042303 [PubMed]


Cutaneous and Breast Apocrine Carcinoma: A Diagnostic Dilemma Between Two Mimicking Malignancies Particularly in Axillary Tumors.
World J Oncol
Kawashima K, Matsushita R, Elsaedy EA, Oshi M, Yamada A, Narui K, Khoury T, Ishikawa T, Endo I, Takabe K.
PMID: 43042183 [PubMed]


Real-world performance of a Food and Drug Administration-approved artificial intelligence tool for mammography in patients with prior breast surgery or indwelling biopsy clips.
Radiol Adv
Ambinder EB, Paulbeck C, Zinzuwadia S, Mullen L, Myers KS, Oluyemi E, Panigrahi B.
PMID: 43042179 [PubMed]


Impact of immersive virtual reality combined with lifestyle modification on upper limb function, pain intensity, and range of motion in post-surgical breast cancer survivors: A randomized controlled trial.
Pak J Med Sci
Irshad A, Babur MN, Umar M, Sultana B.
PMID: 43042128 [PubMed]


Correction: Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model.
Front Public Health
Jin S, Ma X, Yang X, Zhang W, Li H, Gu Y, Wu B.
PMID: 43042028 [PubMed - in process]


Targeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer.
EClinicalMedicine
Glaviano A, Abelman RO, Varkaris A, Varma S, McCann KE, Kumar AP, Diana P, de Bruin RAM, Juric D, Vasan N, Wander SA.
PMID: 43042018 [PubMed]


Efficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies.
Pak J Med Sci
Qian X, Ruan L.
PMID: 43041967 [PubMed]


   
   Artikel 1 - 20 / 224314    Seite 1 von 11216  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1